Literature DB >> 23328081

Emerging role of tyrosine phosphatase, TCPTP, in the organelles of the early secretory pathway.

Madhavi Muppirala1, Vijay Gupta, Ghanshyam Swarup.   

Abstract

T-cell protein tyrosine phosphatase, TCPTP, is a ubiquitously expressed non-receptor type tyrosine phosphatase. There are two splice variants of TCPTP, TC48 and TC45, which differ in their sub-cellular localizations and functions. TC45 is a nuclear protein, which has both nuclear and cytoplasmic substrates, and is involved in many signaling events including endocytic recycling of platelet-derived growth factor β-receptor. TC48 is a predominantly endoplasmic reticulum (ER)-localizing protein, which dephosphorylates some of the substrates of TC45 at the ER. However, recently few specific substrates for TC48 have been identified. These include C3G (RapGEF1), syntaxin 17 and BCR-Abl. TC48 moves from the ER to post-ER compartments, the ER-Golgi intermediate compartment (ERGIC) and Golgi, and it is retrieved back to the ER. The retrieval of ER proteins from post-ER compartments is generally believed as a mechanism of targeting these proteins to the ER. However, it is possible that this shuttling of TC48 serves to regulate signaling in the early secretory pathway. For example, TC48 dephosphorylates phosphorylated C3G at the Golgi and inhibits neurite outgrowth. TC48 interacts with and dephosphorylates syntaxin 17, which is an ER and ERGIC-localizing protein involved in vesicle transport. A yeast two-hybrid screen identified several unique interacting partners of TC48 belonging to two groups - proteins involved in vesicle trafficking and proteins involved in cell adhesion. These interacting proteins could be substrates or regulators of TC48 function and localization. Thus, the role of TC48 seems to be more diverse, which is still to be explored.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23328081     DOI: 10.1016/j.bbamcr.2013.01.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Proteasome regulation by reversible tyrosine phosphorylation at the membrane.

Authors:  Lu Chen; Yanan Zhang; Xin Shu; Qiong Chen; Tiantian Wei; Heman Wang; Xiaorong Wang; Qirou Wu; Xiaomei Zhang; Xiaoyan Liu; Suya Zheng; Lan Huang; Junyu Xiao; Chao Jiang; Bing Yang; Zhiping Wang; Xing Guo
Journal:  Oncogene       Date:  2021-02-18       Impact factor: 9.867

2.  Expression and subcellular localization of the Qa-SNARE syntaxin17 in human eosinophils.

Authors:  Lívia A S Carmo; Felipe F Dias; Kássia K Malta; Kátia B Amaral; Revital Shamri; Peter F Weller; Rossana C N Melo
Journal:  Exp Cell Res       Date:  2015-08-06       Impact factor: 3.905

3.  Host-pathogen interactome analysis of Chikungunya virus envelope proteins E1 and E2.

Authors:  Namrata Dudha; Jyoti Rana; Sreejith Rajasekharan; Reema Gabrani; Amita Gupta; Vijay Kumar Chaudhary; Sanjay Gupta
Journal:  Virus Genes       Date:  2015-01-07       Impact factor: 2.198

4.  Regulation of platelet-activating factor-mediated interleukin-6 promoter activation by the 48 kDa but not the 45 kDa isoform of protein tyrosine phosphatase non-receptor type 2.

Authors:  Geneviève Hamel-Côté; Fanny Lapointe; Steeve Véronneau; Marian Mayhue; Marek Rola-Pleszczynski; Jana Stankova
Journal:  Cell Biosci       Date:  2019-06-25       Impact factor: 7.133

5.  The catalytic activity of TCPTP is auto-regulated by its intrinsically disordered tail and activated by Integrin alpha-1.

Authors:  Jai Prakash Singh; Yang Li; Yi-Yun Chen; Shang-Te Danny Hsu; Rebecca Page; Wolfgang Peti; Tzu-Ching Meng
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 14.919

Review 6.  PTPN2 in the Immunity and Tumor Immunotherapy: A Concise Review.

Authors:  Jiachun Song; Jinxin Lan; Jiaping Tang; Na Luo
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

7.  Soft TCPTP Agonism-Novel Target to Rescue Airway Epithelial Integrity by Exogenous Spermidine.

Authors:  Carlo A Ghisalberti; Rosa M Borzì; Silvia Cetrullo; Flavio Flamigni; Gaetano Cairo
Journal:  Front Pharmacol       Date:  2016-06-03       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.